NCT06614504

Brief Summary

Cigarette smoking remains the leading cause of preventable morbidity and mortality in the US. Use of multiple tobacco products is becoming increasingly prevalent, with dual use of e-cigarettes and cigarettes representing the most common combination. Though e-cigarettes are not without risk, completely switching from cigarettes to e-cigarettes likely reduces risk for tobacco-related harm. However, many established dual users maintain long-term smoking and the majority who use e-cigarettes non-daily are at an even greater risk for prolonged smoking than exclusive cigarette smokers. The Food and Drug Administration Center for Tobacco Products (FDA CTP) has announced plans to implement a nicotine-limiting product standard, capping the nicotine in cigarettes at a minimally or non-addictive level. Randomized controlled trials (RCTs) demonstrate that adults who exclusively smoke cigarettes respond to very low nicotine content (VLNC) cigarettes with reductions in smoking, demand, and dependence. However, nicotine reduction RCTs to date have excluded people who regularly use e-cigarettes and therefore it remains unclear how a nicotine-limiting standard for cigarettes would affect smoking among dual users. Given the potential substitutability of e-cigarettes for cigarettes, reducing the nicotine in cigarettes could promote a transition to exclusive e-cigarette use among dual users unable to completely quit nicotine, but only if sufficiently appealing e-cigarettes remain available. E-cigarettes containing 5% nicotine-salt solution are currently most popular in the US, but policy makers have proposed restricting e-cigarettes to ≤ 2% nicotine to curb youth e-cigarette use, and several states have already set limits to reduce nicotine in e-cigarettes. Prior laboratory studies indicate that higher vs lower nicotine e-cigarettes serve as better substitutes for cigarettes among adult dual users. As such, a restriction on e-cigarette nicotine concentration could undermine the potential for e-cigarettes to substitute for cigarettes and diminish the benefits of a nicotine-limiting standard for cigarettes among dual users. This study is a 12-week double-blind 2 cigarette level (Normal Nicotine vs Very Low Nicotine) x 2 e-cigarette level (High Nicotine vs Low Nicotine) between-subjects factorial trial to investigate how a nicotine-limiting standard for cigarettes affects adult dual users and whether these effects are impacted by constraints on e-cigarette nicotine concentration. Outcome measures include cigarettes per day, cigarette dependence, and toxicant exposure. The research is highly relevant to FDA CTP domains of Addiction and Behavior because it will test whether reducing the nicotine content of cigarettes reduces smoking and dependence, and whether these effects are moderated by the availability of high vs low nicotine e-cigarettes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for phase_2

Timeline
30mo left

Started Nov 2024

Typical duration for phase_2

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Nov 2024Sep 2028

First Submitted

Initial submission to the registry

September 23, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 26, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

June 27, 2025

Status Verified

September 1, 2024

Enrollment Period

3.8 years

First QC Date

September 23, 2024

Last Update Submit

June 23, 2025

Conditions

Keywords

CigarettesE-cigarettes

Outcome Measures

Primary Outcomes (1)

  • Number of cigarettes smoked per day

    12 weeks

Study Arms (4)

RC 1 + REC 1

EXPERIMENTAL

Research cigarettes #1 plus research e-cigarettes #1

Other: Varying the nicotine content of cigarettesOther: Varying the nicotine content of e-cigarettes

RC 1 + REC 2

EXPERIMENTAL

Research cigarettes #1 plus research e-cigarettes #2

Other: Varying the nicotine content of cigarettesOther: Varying the nicotine content of e-cigarettes

RC 2 + REC 1

EXPERIMENTAL

Research cigarettes #2 plus research cigarettes #1

Other: Varying the nicotine content of cigarettesOther: Varying the nicotine content of e-cigarettes

RC 2 + REC 2

EXPERIMENTAL

Research cigarettes #2 + research e-cigarettes #2

Other: Varying the nicotine content of cigarettesOther: Varying the nicotine content of e-cigarettes

Interventions

Altering the nicotine content of the tobacco research cigarettes

Also known as: Comparing normal nicotine content (RC 1) to very low nicotine content (RC 2)
RC 1 + REC 1RC 1 + REC 2RC 2 + REC 1RC 2 + REC 2

Altering the nicotine content of the research e-cigarettes

Also known as: Comparing high nicotine content (REC 1) to low nicotine content (REC 2)
RC 1 + REC 1RC 1 + REC 2RC 2 + REC 1RC 2 + REC 2

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Regular use of tobacco
  • year of age or older
  • Speak, comprehend and read English well enough to complete study procedures

You may not qualify if:

  • Pregnant, trying to become pregnant, or nursing
  • Under the age of 21
  • Health conditions that could undermine ability to complete the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brown University

Providence, Rhode Island, 02903, United States

RECRUITING

University of Vermont

Burlington, Vermont, 05405, United States

RECRUITING

MeSH Terms

Conditions

Tobacco Use DisorderVaping

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersSmokingBehavior

Study Officials

  • Elias Klemperer, PhD

    University of Vermont

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: 2x2 factorial randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 23, 2024

First Posted

September 26, 2024

Study Start

November 1, 2024

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

June 27, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Data will be made available once we have published the results of the parent trials and manuscripts based on secondary analyses of those data, which we anticipate taking approximately three years.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations